{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:46:44Z","timestamp":1791924404379,"version":"4.3.4"},"reference-count":90,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T00:00:00Z","timestamp":1715040000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100022706","name":"Cole Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022706","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010785","name":"Canada First Research Excellence Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010785","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021202","name":"Alliance de recherche num\u00e9rique du Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021202","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008762","name":"Genome Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019217","name":"Institut de Valorisation des Donn\u00e9es","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019217","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005242","name":"Universit\u00e9 de Montr\u00e9al","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005242","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000023","name":"Government of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000023","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013062","name":"G\u00e9nome Qu\u00e9bec","doi-asserted-by":"publisher","award":["4524"],"award-info":[{"award-number":["4524"]}],"id":[{"id":"10.13039\/100013062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013062","name":"G\u00e9nome Qu\u00e9bec","doi-asserted-by":"publisher","award":["13528"],"award-info":[{"award-number":["13528"]}],"id":[{"id":"10.13039\/100013062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.celrep.2024.114260","type":"journal-article","created":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T08:31:57Z","timestamp":1717489917000},"page":"114260","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Immunotherapeutic targeting of surfaceome heterogeneity in AML"],"prefix":"10.1016","volume":"43","author":[{"given":"Marie-Eve","family":"Bordeleau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9ric","family":"Audemard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"M\u00e9tois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Theret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Lisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azer","family":"Farah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Spinella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jalila","family":"Chagraoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ossama","family":"Moujaber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9o","family":"Aubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banafsheh","family":"Khakipoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure","family":"Mallinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Boivin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Mayotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azadeh","family":"Hajmirza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9ric","family":"Bonneil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"B\u00e9liveau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sybille","family":"Pfammatter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Feghaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevi\u00e8ve","family":"Boucher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Gendron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Thibault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Barab\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Lemieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Richard-Carpentier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9e","family":"H\u00e9bert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent-Philippe","family":"Lavall\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe P.","family":"Roux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Sauvageau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2024.114260_bib1","doi-asserted-by":"crossref","first-page":"4622","DOI":"10.1038\/s41467-022-32103-8","article-title":"Unified classification and risk-stratification in Acute Myeloid Leukemia","volume":"13","author":"Tazi","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2024.114260_bib2","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1200\/JCO.2010.31.4310","article-title":"Identification of patients with acute myeloblastic leukemia who benefit from the addition of gemtuzumab ozogamicin: results of the MRC AML15 trial","volume":"29","author":"Burnett","year":"2011","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.celrep.2024.114260_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23147542","article-title":"New Frontiers in Monoclonal Antibodies for the Targeted Therapy of Acute Myeloid Leukemia and Myelodysplastic Syndromes","volume":"23","author":"Gallazzi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.celrep.2024.114260_bib4","article-title":"A perspective of immunotherapy for acute myeloid leukemia: Current advances and challenges","volume":"14","author":"Chen","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.celrep.2024.114260_bib5","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature10098","article-title":"Global quantification of mammalian gene expression control","volume":"473","author":"Schwanhausser","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2024.114260_bib6","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ccell.2022.02.006","article-title":"The proteogenomic subtypes of acute myeloid leukemia","volume":"40","author":"Jayavelu","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2024.114260_bib7","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1182\/blood.2022016033","article-title":"Proteomic and phosphoproteomic landscapes of acute myeloid leukemia","volume":"140","author":"Kramer","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.celrep.2024.114260_bib8","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.ccell.2018.08.014","article-title":"Prospective Isolation and Characterization of Genetically and Functionally Distinct AML Subclones","volume":"34","author":"de Boer","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2024.114260_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/pmic.201600361","article-title":"Integrated analysis of proteome, phosphotyrosine-proteome, tyrosine-kinome, and tyrosine-phosphatome in acute myeloid leukemia","volume":"17","author":"Tong","year":"2017","journal-title":"Proteomics"},{"key":"10.1016\/j.celrep.2024.114260_bib10","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/s41375-022-01796-7","article-title":"Proteogenomic analysis of acute myeloid leukemia associates relapsed disease with reprogrammed energy metabolism both in adults and children","volume":"37","author":"Stratmann","year":"2023","journal-title":"Leukemia"},{"key":"10.1016\/j.celrep.2024.114260_bib11","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.3324\/haematol.2021.279672","article-title":"Clinical relevance of proteomic profiling in de novo pediatric acute myeloid leukemia: a Children's Oncology Group study","volume":"107","author":"Hoff","year":"2022","journal-title":"Haematologica"},{"key":"10.1016\/j.celrep.2024.114260_bib12","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","article-title":"Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia","volume":"368","author":"Ley","year":"2013","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.celrep.2024.114260_bib13","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s41586-018-0623-z","article-title":"Functional genomic landscape of acute myeloid leukaemia","volume":"562","author":"Tyner","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2024.114260_bib14","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1038\/ng.3371","article-title":"The transcriptomic landscape and directed chemical interrogation of MLL-rearranged acute myeloid leukemias","volume":"47","author":"Lavallee","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.celrep.2024.114260_bib15","doi-asserted-by":"crossref","first-page":"e529","DOI":"10.1038\/bcj.2017.10","article-title":"A novel approach for the identification of efficient combination therapies in primary human acute myeloid leukemia specimens","volume":"7","author":"Baccelli","year":"2017","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.celrep.2024.114260_bib16","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nmeth.2847","article-title":"Identification of small molecules that support human leukemia stem cell activity ex\u00a0vivo","volume":"11","author":"Pabst","year":"2014","journal-title":"Nat. Methods"},{"key":"10.1016\/j.celrep.2024.114260_bib17","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1182\/blood-2014-07-591529","article-title":"EVI1-rearranged acute myeloid leukemias are characterized by distinct molecular alterations","volume":"125","author":"Lavallee","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.celrep.2024.114260_bib18","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1038\/leu.2016.19","article-title":"Identification of MYC mutations in acute myeloid leukemias with NUP98-NSD1 translocations","volume":"30","author":"Lavallee","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.celrep.2024.114260_bib19","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1182\/blood-2016-03-703868","article-title":"RNA-sequencing analysis of core binding factor AML identifies recurrent ZBTB7A mutations and defines RUNX1-CBFA2T3 fusion signature","volume":"127","author":"Lavallee","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.celrep.2024.114260_bib20","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1182\/blood-2016-03-705053","article-title":"Chemo-genomic interrogation of CEBPA mutated AML reveals recurrent CSF3R mutations and subgroup sensitivity to JAK inhibitors","volume":"127","author":"Lavallee","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.celrep.2024.114260_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2016.36","article-title":"Transcriptome analysis of G protein-coupled receptors in distinct genetic subgroups of acute myeloid leukemia: identification of potential disease-specific targets","volume":"6","author":"Maiga","year":"2016","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.celrep.2024.114260_bib22","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1158\/1078-0432.CCR-17-1259","article-title":"Chemogenomic Landscape of RUNX1-mutated AML Reveals Importance of RUNX1 Allele Dosage in Genetics and Glucocorticoid Sensitivity","volume":"23","author":"Simon","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.celrep.2024.114260_bib23","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1038\/s41375-018-0069-1","article-title":"Transcriptomic landscape of acute promyelocytic leukemia reveals aberrant surface expression of the platelet aggregation agonist Podoplanin","volume":"32","author":"Lavallee","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.celrep.2024.114260_bib24","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1182\/bloodadvances.2018028480","article-title":"Complex karyotype AML displays G2\/M signature and hypersensitivity to PLK1 inhibition","volume":"3","author":"Moison","year":"2019","journal-title":"Blood Adv."},{"key":"10.1016\/j.celrep.2024.114260_bib25","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ccell.2019.06.003","article-title":"Mubritinib Targets the Electron Transport Chain Complex I and Reveals the Landscape of OXPHOS Dependency in Acute Myeloid Leukemia","volume":"36","author":"Baccelli","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2024.114260_bib26","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41375-019-0485-x","article-title":"Genetic characterization of ABT-199 sensitivity in human AML","volume":"34","author":"Bisaillon","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.celrep.2024.114260_bib27","doi-asserted-by":"crossref","first-page":"4793","DOI":"10.1182\/bloodadvances.2021005828","article-title":"HMGA2 expression defines a subset of human AML with immature transcriptional signature and vulnerability to G2\/M inhibition","volume":"6","author":"Moison","year":"2022","journal-title":"Blood Adv."},{"key":"10.1016\/j.celrep.2024.114260_bib28","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s40364-022-00390-4","article-title":"Integrated multiomic approach for identification of novel immunotherapeutic targets in AML","volume":"10","author":"Kohnke","year":"2022","journal-title":"Biomark. Res."},{"key":"10.1016\/j.celrep.2024.114260_bib29","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.ccell.2017.09.004","article-title":"Integrating Proteomics and Transcriptomics for Systematic Combinatorial Chimeric Antigen Receptor Therapy of AML","volume":"32","author":"Perna","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2024.114260_bib30","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1074\/mcp.M112.021931","article-title":"A proteomics and transcriptomics approach to identify leukemic stem cell (LSC) markers","volume":"12","author":"Bonardi","year":"2013","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.celrep.2024.114260_bib31","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.exphem.2018.09.004","article-title":"The Human Cell Atlas bone marrow single-cell interactive web portal","volume":"68","author":"Hay","year":"2018","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.celrep.2024.114260_bib32","article-title":"SPAT: Surface Protein Annotation Tool","author":"Spinella","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.celrep.2024.114260_bib33","doi-asserted-by":"crossref","first-page":"E10988","DOI":"10.1073\/pnas.1808790115","article-title":"The in\u00a0silico human surfaceome","volume":"115","author":"Bausch-Fluck","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2024.114260_bib34","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1093\/bioinformatics\/btaa092","article-title":"SurfaceGenie: a web-based application for prioritizing cell-type-specific marker candidates","volume":"36","author":"Waas","year":"2020","journal-title":"Bioinformatics"},{"key":"10.1016\/j.celrep.2024.114260_bib35","doi-asserted-by":"crossref","first-page":"D383","DOI":"10.1093\/nar\/gkz827","article-title":"Thera-SAbDab: the Therapeutic Structural Antibody Database","volume":"48","author":"Raybould","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.celrep.2024.114260_bib36","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1182\/blood-2015-11-683649","article-title":"GPR56 identifies primary human acute myeloid leukemia cells with high repopulating potential in\u00a0vivo","volume":"127","author":"Pabst","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.celrep.2024.114260_bib37","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1182\/blood-2009-11-254441","article-title":"Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials","volume":"116","author":"Grimwade","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.celrep.2024.114260_bib38","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/leu.2016.309","article-title":"Expression of CD33 is a predictive factor for effect of gemtuzumab ozogamicin at different doses in adult acute myeloid leukaemia","volume":"31","author":"Khan","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.celrep.2024.114260_bib39","first-page":"1261","article-title":"Interleukin-3 receptor alpha chain (CD123) is widely expressed in hematologic malignancies","volume":"86","author":"Munoz","year":"2001","journal-title":"Haematologica"},{"key":"10.1016\/j.celrep.2024.114260_bib40","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1182\/blood.V81.11.3043.3043","article-title":"Acute myeloid leukemia M4 with bone marrow eosinophilia (M4Eo) and inv(16)(p13q22) exhibits a specific immunophenotype with CD2 expression","volume":"81","author":"Adriaansen","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.celrep.2024.114260_bib41","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","article-title":"Genomic Classification and Prognosis in Acute Myeloid Leukemia","volume":"374","author":"Papaemmanuil","year":"2016","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.celrep.2024.114260_bib42","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1182\/blood.2018862383","article-title":"Hepatic leukemia factor is a novel leukemic stem cell regulator in DNMT3A, NPM1, and FLT3-ITD triple-mutated AML","volume":"134","author":"Garg","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.celrep.2024.114260_bib43","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.imbio.2009.06.004","article-title":"The CD300 molecules regulate monocyte and dendritic cell functions","volume":"214","author":"Clark","year":"2009","journal-title":"Immunobiology"},{"key":"10.1016\/j.celrep.2024.114260_bib92","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12014-019-9262-0","article-title":"The plasma peptides of breast versus ovarian cancer","volume":"16","author":"Dufresne","year":"2019","journal-title":"Clin. Proteomics"},{"key":"10.1016\/j.celrep.2024.114260_bib45","doi-asserted-by":"crossref","first-page":"5013","DOI":"10.1182\/blood.V90.12.5013","article-title":"A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning","volume":"90","author":"Miraglia","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.celrep.2024.114260_bib46","doi-asserted-by":"crossref","first-page":"5002","DOI":"10.1182\/blood.V90.12.5002","article-title":"AC133, a novel marker for human hematopoietic stem and progenitor cells","volume":"90","author":"Yin","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.celrep.2024.114260_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22010147","article-title":"Endoglin Targeting: Lessons Learned and Questions That Remain","volume":"22","author":"Liu","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.celrep.2024.114260_bib48","first-page":"2331","article-title":"Characteristics and clinical outcomes of patients with acute myeloid leukemia with inv(3)(q21q26.2) or t, 33(q21-q26.2)","volume":"108","author":"Richard-Carpentier","year":"2023","journal-title":"Haematologica"},{"key":"10.1016\/j.celrep.2024.114260_bib49","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1182\/blood-2017-01-763581","article-title":"Endoglin: a novel target for therapeutic intervention in acute leukemias revealed in xenograft mouse models","volume":"129","author":"Dourado","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.celrep.2024.114260_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2020.e05242","article-title":"Therapeutic effect of TRC105 and decitabine combination in AML xenografts","volume":"6","author":"Baik","year":"2020","journal-title":"Heliyon"},{"key":"10.1016\/j.celrep.2024.114260_bib51","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1309\/AJCPG8XH7ZONAKXK","article-title":"CD105 (endoglin) is highly overexpressed in a subset of cases of acute myeloid leukemias","volume":"140","author":"Chakhachiro","year":"2013","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.celrep.2024.114260_bib52","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2022.2131229","article-title":"Fully murine CD105-targeted CAR-T cells provide an immunocompetent model for CAR-T cell biology","volume":"11","author":"Lontos","year":"2022","journal-title":"OncoImmunology"},{"key":"10.1016\/j.celrep.2024.114260_bib53","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232314885","article-title":"Comprehensive Transcriptomic Analysis of VISTA in Acute Myeloid Leukemia: Insights into Its Prognostic Value","volume":"23","author":"Pagliuca","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.celrep.2024.114260_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.879471","article-title":"TIM-3 Expression Level on AML Blasts Correlates With Presence of Core Binding Factor Translocations Rather Than Clinical Outcomes","volume":"12","author":"Hong","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.celrep.2024.114260_bib55","doi-asserted-by":"crossref","first-page":"5009","DOI":"10.1073\/pnas.1100551108","article-title":"Prospective separation of normal and leukemic stem cells based on differential expression of TIM3, a human acute myeloid leukemia stem cell marker","volume":"108","author":"Jan","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2024.114260_bib56","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.stem.2010.11.014","article-title":"TIM-3 is a promising target to selectively kill acute myeloid leukemia stem cells","volume":"7","author":"Kikushige","year":"2010","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.celrep.2024.114260_bib57","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ebiom.2017.07.018","article-title":"The Tim-3-galectin-9 Secretory Pathway is Involved in the Immune Escape of Human Acute Myeloid Leukemia Cells","volume":"22","author":"Goncalves Silva","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.celrep.2024.114260_bib58","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1182\/blood.V90.4.1643","article-title":"Expression of the neural cell adhesion molecule CD56 is associated with short remission duration and survival in acute myeloid leukemia with t(8;21)(q22;q22)","volume":"90","author":"Baer","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.celrep.2024.114260_bib59","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1038\/sj.leu.2401840","article-title":"Detection of acute leukemia cells with mixed lineage leukemia (MLL) gene rearrangements by flow cytometry using monoclonal antibody 7.1","volume":"14","author":"Wuchter","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.celrep.2024.114260_bib60","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1182\/blood-2018-12-889725","article-title":"NCAM1 (CD56) promotes leukemogenesis and confers drug resistance in AML","volume":"133","author":"Sasca","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.celrep.2024.114260_bib61","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1158\/1535-7163.MCT-15-0067","article-title":"AGS67E, an Anti-CD37 Monomethyl Auristatin E Antibody-Drug Conjugate as a Potential Therapeutic for B\/T-Cell Malignancies and AML: A New Role for CD37 in AML","volume":"14","author":"Pereira","year":"2015","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.celrep.2024.114260_bib62","article-title":"CD37 high expression as a potential biomarker and association with poor outcome in\u00a0acute\u00a0myeloid leukemia","volume":"40","author":"Zhang","year":"2020","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.celrep.2024.114260_bib63","article-title":"FEV Maintains Homing and Expansion by Activating ITGA4 Transcription in Primary and Relapsed AML","volume":"12","author":"Zhang","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.celrep.2024.114260_bib64","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1038\/s41375-022-01696-w","article-title":"METTL3 mediates chemoresistance by enhancing AML homing and engraftment via ITGA4","volume":"36","author":"Li","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.celrep.2024.114260_bib65","doi-asserted-by":"crossref","first-page":"5590","DOI":"10.1002\/cam4.5409","article-title":"Immune checkpoint gene VSIR predicts patient prognosis in acute myeloid leukemia and myelodysplastic syndromes","volume":"12","author":"Yao","year":"2023","journal-title":"Cancer Med."},{"key":"10.1016\/j.celrep.2024.114260_bib66","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13045-023-01410-y","article-title":"Targeting STAT3-VISTA axis to suppress tumor aggression and burden in acute myeloid leukemia","volume":"16","author":"Mo","year":"2023","journal-title":"J.\u00a0Hematol. Oncol."},{"key":"10.1016\/j.celrep.2024.114260_bib67","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ebiom.2019.05.025","article-title":"LGALS3 is connected to CD74 in a previously unknown protein network that is associated with poor survival in patients with AML","volume":"44","author":"Ruvolo","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.celrep.2024.114260_bib68","doi-asserted-by":"crossref","first-page":"11008","DOI":"10.1073\/pnas.0704271104","article-title":"CD96 is a leukemic stem cell-specific marker in human acute myeloid leukemia","volume":"104","author":"Hosen","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2024.114260_bib69","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/ejh.12938","article-title":"MRP1 protein expression in leukemic stem cells as a negative prognostic marker in acute myeloid leukemia patients","volume":"99","author":"Paprocka","year":"2017","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.celrep.2024.114260_bib70","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/cyto.b.20403","article-title":"Determination of P-glycoprotein, MDR-related protein 1, breast cancer resistance protein, and lung-resistance protein expression in leukemic stem cells of acute myeloid leukemia","volume":"74","author":"de Figueiredo-Pontes","year":"2008","journal-title":"Cytometry B Clin. Cytom."},{"key":"10.1016\/j.celrep.2024.114260_bib71","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41467-023-43843-6","article-title":"TMIGD2 is an orchestrator and therapeutic target on human acute myeloid leukemia stem cells","volume":"15","author":"Wang","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2024.114260_bib72","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1038\/s41587-023-01714-x","article-title":"Global detection of human variants and isoforms by deep proteome sequencing","volume":"41","author":"Sinitcyn","year":"2023","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.celrep.2024.114260_bib73","doi-asserted-by":"crossref","first-page":"D543","DOI":"10.1093\/nar\/gkab1038","article-title":"The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences","volume":"50","author":"Perez-Riverol","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.celrep.2024.114260_bib74","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic\/Dendritic Neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.celrep.2024.114260_bib75","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","article-title":"Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel","volume":"129","author":"Dohner","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.celrep.2024.114260_bib76","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1038\/s41467-020-17549-y","article-title":"Copper bioavailability is a KRAS-specific vulnerability in colorectal cancer","volume":"11","author":"Aubert","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2024.114260_bib77","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/nbt.1511","article-title":"MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification","volume":"26","author":"Cox","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.celrep.2024.114260_bib78","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/nprot.2017.147","article-title":"Proteome-wide identification of ubiquitin interactions using UbIA-MS","volume":"13","author":"Zhang","year":"2018","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.celrep.2024.114260_bib79","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nmeth.2557","article-title":"The CRAPome: a contaminant repository for affinity purification-mass spectrometry data","volume":"10","author":"Mellacheruvu","year":"2013","journal-title":"Nat. Methods"},{"key":"10.1016\/j.celrep.2024.114260_bib80","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nbt.4042","article-title":"Multiplexed droplet single-cell RNA-sequencing using natural genetic variation","volume":"36","author":"Kang","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.celrep.2024.114260_bib81","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1186\/s13059-019-1865-2","article-title":"Vireo: Bayesian demultiplexing of pooled single-cell RNA-seq data without genotype reference","volume":"20","author":"Huang","year":"2019","journal-title":"Genome Biol."},{"key":"10.1016\/j.celrep.2024.114260_bib82","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1093\/bioinformatics\/btab358","article-title":"Cellsnp-lite: an efficient tool for genotyping single cells","volume":"37","author":"Huang","year":"2021","journal-title":"Bioinformatics"},{"key":"10.1016\/j.celrep.2024.114260_bib83","article-title":"UMAP: Uniform Manifold Approximation and Projection for Dimension Reduction","author":"McInnes","year":"2018","journal-title":"ArXiv"},{"key":"10.1016\/j.celrep.2024.114260_bib84","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","article-title":"Fast, sensitive and accurate integration of single-cell data with Harmony","volume":"16","author":"Korsunsky","year":"2019","journal-title":"Nat. Methods"},{"key":"10.1016\/j.celrep.2024.114260_bib85","doi-asserted-by":"crossref","first-page":"D596","DOI":"10.1093\/nar\/gkab1020","article-title":"DISCO: a database of Deeply Integrated human Single-Cell Omics data","volume":"50","author":"Li","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.celrep.2024.114260_bib86","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.celrep.2024.114260_bib87","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/ng.2653","article-title":"The Genotype-Tissue Expression (GTEx) project","volume":"45","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.celrep.2024.114260_bib88","doi-asserted-by":"crossref","DOI":"10.1126\/science.1260419","article-title":"Proteomics. Tissue-based map of the human proteome","volume":"347","author":"Uhlen","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.celrep.2024.114260_bib89","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1182\/blood-2009-02-203828","article-title":"Platelet membrane proteomics: a novel repository for functional research","volume":"114","author":"Lewandrowski","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.celrep.2024.114260_bib90","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J.\u00a0Roy. Stat. Soc. B"}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124724005886?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124724005886?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T12:38:22Z","timestamp":1779453502000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124724005886"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":90,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S2211124724005886"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2024.114260","relation":{},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunotherapeutic targeting of surfaceome heterogeneity in AML","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2024.114260","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"114260"}}